Raytheon Technologies

Raytheon Technologies(RTX) (Q3FY25) Recovery priced in but execution risk persists

Highlights of the report

RTX remains a high-quality aerospace and defense franchise with strong end-market exposure and
balance-sheet resilience. However, at current expectations, much of the recovery narrative appears embedded,
while execution risks at Pratt & Whitney continue to influence margins, cash flow, and return metrics.

Raytheon Technologies (RTX) Quarterly Report Q3FY23, Stock Research

CrispIdea equity reports provide valuable insights to investors who may be individuals and organizations involved in the world of finance and investment like private equity houses, broking firms, hedge funds, investment advisory firms, mutual funds, banks and corporations. This research report is useful for M&A, business & investment analysis to all students and researchers also.

 

CrispIdea equity reports include basic financials, strategic analysis, competitive landscape assessments, stock performance, stock analysis and future growth potential evaluation. CrispIdea utilizes a proprietary blend of fundamental and technical analysis, offering a unique perspective. Reports present clear investment recommendations (“BUY,” “HOLD,” or “SELL”).

 

Our established reputation and track record advocates that our research carries weight within the investment community. Do connect with us, if you are looking for customized research, equity valuation, recommendation, analysis and market recommendation for any specific company, sector and industry.

RTX Corporation, an aerospace and defense company, provides systems and services for the commercial, military, and government customers in the United States and internationally.

RTX delivered a solid operational performance in Q3FY25, withrevenueincreasing to$22.5bn from $20.1bn in the prior-year quarter, supported by broad-based strength across commercial aerospace and defense end markets.

In the last 3 months the stock has given a return of 12.48%.

Highlights

Valuation

– Enterprise Value
– CrispIdea Forecast
– Economic Value Added Analysis
– Discounted Cash Flow Analysis
– P/E Analysis
– Peer Valuation
– CrispIdea Forecast Relative to Consensus
– Consensus History and Surprise
– Consensus Momentum

Actual & Historical Performance

– Income Statement
– Balance Sheet
– Cash Flow
– 10 Year Historical Performance
– Ratio Analysis
– Du Pont Analysis
– ROIC & ROCE Analysis
– Segment Performance
– Key Metrics
– M&A Deals

Peer Performance

– Summary
– Profitability
– Growth
– Price Performance

Ownership

Stock Price Performance

Crispidea Coverage

Report details

Raytheon Technologies(RTX) (Q3FY25) Recovery priced in but execution risk persists

Price

$272.00

Company Reports

Sector Reports